当前位置:首页 - 行情中心 - 乐凯胶片(600135) - 财务分析 - 利润表

乐凯胶片

(600135)

  

流通市值:38.07亿  总市值:38.07亿
流通股本:5.53亿   总股本:5.53亿

利润表

报告期2024-12-312024-09-302024-06-302024-03-31
公司类型通用通用通用通用
一、营业总收入1,485,017,726.291,099,338,506.81765,871,458.71353,923,072.11
营业收入1,485,017,726.291,099,338,506.81765,871,458.71353,923,072.11
二、营业总成本1,565,111,614.141,171,101,868.62806,348,301376,831,657.85
营业成本1,274,641,089.35952,904,198.73666,106,642.47308,901,235.54
税金及附加13,395,929.879,647,296.917,209,026.733,027,428.52
销售费用59,242,389.5343,774,161.8829,097,770.7913,565,385.34
管理费用133,494,897.98100,730,103.7466,901,510.1329,731,891.55
研发费用101,591,877.0377,981,824.8350,605,143.4522,330,133.16
财务费用-17,254,569.62-13,935,717.47-13,571,792.57-724,416.26
其中:利息费用2,897,079.482,510,865.851,515,651.091,037,027.1
其中:利息收入18,211,639.41-16,029,230.7214,899,429.63-1,975,958.76
加:公允价值变动收益9,027,777.797,506,957.415,461,505.982,868,168.27
加:投资收益2,258,502.381,811,204.731,609,656.15-124,614.8
资产处置收益-53,152.159,045.95-101.182,359.64
资产减值损失(新)-14,842,292.57-637,196.57--
信用减值损失(新)-8,352,490.98-2,968,538.08-2,686,423.55-2,096,023.36
其他收益36,381,820.8611,865,445.188,274,706.664,317,905.09
营业利润平衡项目0000
四、营业利润-55,673,722.52-54,176,443.19-27,817,498.23-17,940,790.9
加:营业外收入1,663,797.2858,702.13545,636.52216,486.9
减:营业外支出553,699.7534,349.76471,540.921,610.26
利润总额平衡项目0000
五、利润总额-54,563,625.02-53,852,090.82-27,743,402.61-17,745,914.26
减:所得税费用6,520,053.572,660,303.563,470,112.961,482,115.59
六、净利润-61,083,678.59-56,512,394.38-31,213,515.57-19,228,029.85
持续经营净利润-61,083,678.59-56,512,394.38-31,213,515.57-19,228,029.85
归属于母公司股东的净利润-62,261,405.91-57,356,819.32-31,840,498.7-19,664,836.1
少数股东损益1,177,727.32844,424.94626,983.13436,806.25
(一)基本每股收益-0.11-0.1-0.06-0.04
(二)稀释每股收益-0.11-0.1-0.06-0.04
八、其他综合收益-3,516,792.83---
归属于母公司股东的其他综合收益-3,516,792.83---
九、综合收益总额-64,600,471.42-56,512,394.38-31,213,515.57-19,228,029.85
归属于母公司股东的综合收益总额-65,778,198.74-57,356,819.32-31,840,498.7-19,664,836.1
归属于少数股东的综合收益总额1,177,727.32844,424.94626,983.13436,806.25
公告日期2025-03-282024-10-312024-08-302024-04-25
审计意见(境内)标准无保留意见
TOP↑